Others have shown that CGM appears to be safe and comparable to fingerstick monitoring in type 2 diabetes pregnancy [51, 53,54,55], but have lacked statistical power to examine effectiveness on pregnancy outcomes [53, 56, 57]
This is similar to what we see with other forms of significant weight loss, where changes in body composition can influence the menstrual cycle. I also asked if there are any gynecological issues that would prevent a doctor from prescribing a GLP-1 medication for weight loss
Efficacy of SGLT2i + DPP4i FDCs Evidence from numerous clinical trials suggest that SGLT2i + DPP4i FDCs are effective and safe in controlling glycemic parameters in patients with T2DM
And in the other
And now women in midlife have this comprehensive, medically backed guide to their perimenopause symptoms
Even when the main compound patent expires, generic competitors must navigate a growing web of patents, making litigation and the delay of any market entry almost inevitable